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Objective
Blood pressure (BP) monitors are widely available and
easy for patients to use. Systematic reviews [1-3] show
that home monitoring of BP improves BP control but
there is significant heterogeneity between studies, and
meta regression has only been able to explain part of
the heterogeneity, with concomitant interventions being
a possible factor.
Most evidence comes from trials of patients who have
poorly controlled blood pressure at baseline, although
not usually explicitly stated in trial or review title. How-
ever many hypertensive patients using home monitors
may have BP below the recommended target
Two large recent UK RCTs [4,5] have been carried out
with very different inclusion criteria and interventions.
T h eo b j e c t i v ei st oc o m p a r et h em a i nf i n d i n g so ft h e s e
trials and assess how far difference between the trial
populations might explain the apparent difference in the
efficacy of the intervention between the two trials.
Methods
In 2007-9, 381 hypertensive stroke patients were
recruited from stroke services in London, and randomly
allocated, at home, to either home BP monitoring
(n=187), with ongoing telephone support from a nurse,
or usual care (n=194). Patients were included without
any restriction on baseline BP [4].
The TASMINH trial [5] randomised 527 primary care
patients with baseline BP between 140/90 and 200/100,
to a self management program (n=263) or control
(n=264). The program involved two training sessions for
patients, so that they could increase their medications
when necessary, without consulting the GP.
The primary endpoint for both trials was change in
mean systolic BP between baseline and 12 months fol-
low up after adjusting for baseline BP. A post hoc sub-
group analysis of those patients in the stroke study with
baseline BP between 140/90 and 200/100 was carried
out for comparison.
Results
Follow up rates for survivors were over 90% in both
trials.
Intervention effect in the TASMINH trial was 5.4(2.4
to 8.5); n=480, and was 0.3(-3.6 to 4.80) in the stroke
trial; n=337.
Of 1650 patients assessed for eligibility in the TAS-
MINH trial, 916 (55%) had BP less than 140/90 and 48
had BP above 200/100. These patients were excluded
prior to randomisation.
133 (40%) patients in the stroke trial had baseline BP
between 140/90 and 200/100; the intervention effect in
this group was 5.9(-0.3 to 12.0) ; p=0.02 for interaction.
Conclusions
Whether or not patients with controlled hypertension,
who comprise more than half the hypertensive popula-
tion, are included, may explain the difference in effect
size between these 2 trials.
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